✦ LIBER ✦

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

✍ Scribed by M.S. Aapro; J. Bohlius; D.A. Cameron; Lissandra Dal Lago; J. Peter Donnelly; N. Kearney; G.H. Lyman; R. Pettengell; V.C. Tjan-Heijnen; J. Walewski; Damien C. Weber; C. Zielinski

Book ID: 116430589
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 523 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2010.10.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EORTC guidelines for the use of granuloc

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

✍ M.S. Aapro; D.A. Cameron; R. Pettengell; J. Bohlius; J. Crawford; M. Ellis; N. K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Primary prophylaxis with granulocyte col

Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis

✍ Sophie Lee, Angela Knox, Irene S. L. Zeng, Christin Coomarasamy, Hilary Blackloc 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 156 KB